Reports for TEVA CANADA LIMITED
Company Name
TEVA CANADA LIMITED
Shortage reports
Actual shortage:
214 (7%)
Anticipated shortage:
0 (0%)
Avoided shortage:
10 (0%)
Resolved:
2706 (92%)
2930
Discontinuation Reports
To be discontinued:
2 (1%)
Discontinued:
298 (99%)
Reversed:
0 (0%)
300
363 (11%)
99 (46%)
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| TEVA-ATENOLOL | 25MG | TABLET | Actual shortage | 2020-01-24 | 2020-01-24 | 104310 |
| TEVA-ATENOLOL | 50MG | TABLET | Resolved | 2021-07-08 | 2021-08-13 | 142207 |
| TEVA-ATENOLOL | 100MG | TABLET | Resolved | 2021-07-22 | 2021-08-13 | 142899 |
| TEVA-ATENOLOL | 100MG | TABLET | Resolved | 2023-06-20 | 2023-07-05 | 195751 |
| TEVA-ATENOLOL | 50MG | TABLET | Resolved | 2023-06-20 | 2023-07-05 | 195772 |
| TEVA-ATENOLOL | 50MG | TABLET | Resolved | 2023-06-20 | 2023-07-05 | 195882 |
| TEVA-ATENOLOL | 50MG | TABLET | Resolved | 2022-11-14 | 2023-10-05 | 174610 |
| TEVA-ATENOLOL | 50MG | TABLET | Resolved | 2025-03-06 | 2025-04-10 | 252056 |
| TEVA-ATENOLOL | 100MG | TABLET | Resolved | 2025-03-06 | 2025-04-10 | 252072 |
| TEVA-ATENOLOL | 50MG | TABLET | Resolved | 2023-01-12 | 2023-10-05 | 180900 |
| TEVA-ATENOLOL | 100MG | TABLET | Resolved | 2023-04-27 | 2023-10-04 | 190773 |
| TEVA-ATENOLOL/CHLORTHALIDONE | 25MG 100MG | TABLET | Resolved | 2017-03-13 | 2020-01-21 | 952 |
| TEVA-ATOMOXETINE | 40MG | CAPSULE | Resolved | 2017-08-01 | 2018-02-21 | 17853 |
| TEVA-ATOMOXETINE | 10MG | CAPSULE | Resolved | 2020-01-30 | 2020-02-13 | 104881 |
| TEVA-ATOMOXETINE | 60MG | CAPSULE | Resolved | 2017-11-16 | 2018-02-21 | 29447 |
| TEVA-ATOMOXETINE | 80MG | CAPSULE | Resolved | 2019-08-22 | 2019-11-07 | 92166 |
| TEVA-ATOMOXETINE | 25MG | CAPSULE | Resolved | 2024-04-05 | 2024-07-03 | 224451 |
| TEVA-ATOMOXETINE | 60MG | CAPSULE | Resolved | 2020-09-24 | 2021-03-25 | 125010 |
| TEVA-ATOMOXETINE | 25MG | CAPSULE | Resolved | 2020-03-26 | 2021-04-15 | 109632 |
| TEVA-ATOMOXETINE | 18MG | CAPSULE | Resolved | 2020-04-02 | 2021-04-15 | 110670 |
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| CLOXACILLIN SODIUM FOR INJECTION | 1G | POWDER FOR SOLUTION | Discontinued | 2017-06-27 | 2017-06-27 | 14018 |
| CLOXACILLIN SODIUM FOR INJECTION | 2G | POWDER FOR SOLUTION | Discontinued | 2017-06-27 | 2017-06-27 | 14021 |
| DOCETAXEL INJECTION | Discontinued | 2018-10-12 | 2018-10-12 | 63937 | ||
| DOCETAXEL INJECTION | Discontinued | 2018-10-12 | 2018-10-12 | 63940 | ||
| EPIRUBICIN FOR INJECTION | 2MG | SOLUTION | Discontinued | 2020-10-22 | 2020-10-24 | 126906 |
| EPTIFIBATIDE INJECTION | Discontinued | 2020-02-13 | 2020-02-13 | 106170 | ||
| EPTIFIBATIDE INJECTION | 0.75MG | SOLUTION | Discontinued | 2017-06-27 | 2017-06-27 | 14024 |
| EPTIFIBATIDE INJECTION | Discontinued | 2020-02-13 | 2020-02-13 | 106176 | ||
| EPTIFIBATIDE INJECTION | 2MG | SOLUTION | Discontinued | 2017-06-27 | 2017-06-27 | 14027 |
| FLUDARABINE PHOSPHATE FOR INJECTION | 25MG | SOLUTION | Discontinued | 2025-10-22 | 2025-10-22 | 257579 |
| GEMCITABINE FOR INJECTION | Discontinued | 2018-10-12 | 2018-10-12 | 63970 | ||
| GEMCITABINE FOR INJECTION | Discontinued | 2018-10-12 | 2018-10-12 | 63967 | ||
| GEMCITABINE FOR INJECTION | Discontinued | 2020-02-13 | 2020-02-13 | 106155 | ||
| GEMCITABINE FOR INJECTION | 1G | POWDER FOR SOLUTION | Discontinued | 2017-06-27 | 2017-06-27 | 14033 |
| HYDROCORTISONE SODIUM SUCCINATE FOR INJECTION | Discontinued | 2019-04-11 | 2019-04-11 | 81337 | ||
| HYDROCORTISONE SODIUM SUCCINATE FOR INJECTION | Discontinued | 2019-04-11 | 2019-04-11 | 81344 | ||
| HYDROCORTISONE SODIUM SUCCINATE FOR INJECTION | Discontinued | 2019-04-11 | 2019-04-11 | 81330 | ||
| HYDROCORTISONE SODIUM SUCCINATE INJECTION | Discontinued | 2019-04-11 | 2019-04-11 | 81347 | ||
| LEUCOVORIN CALCIUM INJECTION | 10MG | SOLUTION | Discontinued | 2017-06-27 | 2017-06-27 | 14036 |
| LINEZOLID INJECTION | Discontinued | 2020-02-13 | 2020-02-13 | 106173 |